Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
100
datasets available to search
ShareScore release 0.9.0
Dataset results
100 results for “BCD”
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)
ClinicalTrials.gov study NCT03912415. IPD Sharing: NO. Countries: 4. Publications: 0.
Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT02744222. IPD Sharing: NO. Countries: 1. Publications: 0.
Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis
ClinicalTrials.gov study NCT03476993. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
ClinicalTrials.gov study NCT07078994. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose Escalation Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of BCD-132 in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT03551275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
ClinicalTrials.gov study NCT03288870. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects
ClinicalTrials.gov study NCT07181694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis
ClinicalTrials.gov study NCT03598751. IPD Sharing: NO. Countries: 2. Publications: 0.
An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06668792. IPD Sharing: NO. Countries: 1. Publications: 0.
An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN
ClinicalTrials.gov study NCT06987864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT05802225. IPD Sharing: NO. Countries: 1. Publications: 0.
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07108309. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06296121. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers
ClinicalTrials.gov study NCT02731469. IPD Sharing: NO. Countries: 0. Publications: 0.
Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
ClinicalTrials.gov study NCT02036723. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melan
ClinicalTrials.gov study NCT03913923. IPD Sharing: NO. Countries: 2. Publications: 0.
A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM
ClinicalTrials.gov study NCT06203145. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment
ClinicalTrials.gov study NCT05385744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT07321093. IPD Sharing: NO. Countries: 1. Publications: 0.
First-In-Human Study to Evaluate Safety And Pharmacokinetics of Single Escalating Doses of BCD-147 (Bispecific Anti-HER2/HER2 Antibody) in Healthy Subjects
ClinicalTrials.gov study NCT03912441. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.